| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Angela M Thomas, Kaley J Cargile, Jannelle A Lunn, Lisa E Bake. Characterization of 3,4-methylenedioxypyrovalerone discrimination in female Sprague-Dawley rats. Behavioural pharmacology. vol 32. issue 6. 2021-11-05. PMID:34397448. |
moreover, they confirm the contribution of dopaminergic mechanisms but do not rule out the possible contribution of other neurotransmitter actions to the interoceptive stimulus effects of mdpv. |
2021-11-05 |
2023-08-13 |
rat |
| Valentina Bashkatov. Metabotropic glutamate receptors and nitric oxide in dopaminergic neurotoxicity. World journal of psychiatry. vol 11. issue 10. 2021-11-05. PMID:34733645. |
pd is primarily caused by dysfunction of dopaminergic neurons; however, other neurotransmitter systems are also involved. |
2021-11-05 |
2023-08-13 |
Not clear |
| Juan Pérez-Fernández, Marta Barandela, Cecilia Jiménez-Lópe. The Dopaminergic Control of Movement-Evolutionary Considerations. International journal of molecular sciences. vol 22. issue 20. 2021-10-26. PMID:34681941. |
dopamine is likely the most studied modulatory neurotransmitter, in great part due to characteristic motor deficits in parkinson's disease that arise after the degeneration of the dopaminergic neurons in the substantia nigra |
2021-10-26 |
2023-08-13 |
Not clear |
| Trevor Archer, Marlene Oscar-Berman, Kenneth Blum, Mark Gol. Neurogenetics and Epigenetics in Impulsive Behaviour: Impact on Reward Circuitry. Journal of genetic syndromes & gene therapy. vol 3. issue 3. 2021-10-21. PMID:23264884. |
brain-derived neurotrophic factor (bdnf) affects the development and integrity of the noradrenergic, dopaminergic, serotonergic, glutamatergic, and cholinergic neurotransmitter systems, and plasma levels of the neurotrophin are associated with both cognitive and aggressive impulsiveness. |
2021-10-21 |
2023-08-12 |
Not clear |
| S De Bruyne, T L Boos, L Wyffels, J L Goeman, K C Rice, F De Vo. Synthesis, radiosynthesis and in vivo evaluation of [I]-4-(2-(bis(4-fluorophenyl)methoxy)ethyl)-1-(4-iodobenzyl)piperidine as a selective tracer for imaging the dopamine transporter. Journal of labelled compounds & radiopharmaceuticals. vol 52. issue 8. 2021-10-20. PMID:19746191. |
dopamine transporter (dat) neuroimaging is a useful tool in parkinson's disease diagnosis, staging and follow-up providing information on the integrity of the dopaminergic neurotransmitter system in vivo. |
2021-10-20 |
2023-08-12 |
mouse |
| Ramani S Durvasula, Charles H Hinki. Neuropsychological Dysfunction among HIV Infected Drug Abusers. American journal of infectious diseases. vol 2. issue 2. 2021-10-20. PMID:20467580. |
damage to neurotransmitter systems including the dopaminergic, serotonergic and glutamatergic systems which are affected by both stimulant use and hiv is an alternate explanation. |
2021-10-20 |
2023-08-12 |
human |
| Paulina Gonzalez-Latapi, Nicolas Marotta, Niccolò E Mencacc. Emerging and converging molecular mechanisms in dystonia. Journal of neural transmission (Vienna, Austria : 1996). vol 128. issue 4. 2021-10-15. PMID:33386558. |
examples of these advances are the recognition that multiple dyt-genes are involved in (1) endoplasmic reticulum function and regulation of the integrated stress response (isr) through eukaryotic initiation factor 2 alpha signaling; (2) gene transcription modulation during neurodevelopment; (3) pre-and post-synaptic nigrostriatal dopaminergic signaling; and (4) presynaptic neurotransmitter vesicle release. |
2021-10-15 |
2023-08-13 |
Not clear |
| Banashree Chetia Phukan, Ankumoni Dutta, Satarupa Deb, Rubul Saikia, Muhammed Khairujjaman Mazumder, Rajib Paul, Pallab Bhattacharya, Rajat Sandhir, Anupom Bora. Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson's disease: involvement of anti-inflammatory response. Experimental brain research. 2021-10-11. PMID:34633467. |
although the etiology of parkinson's disease (pd) is poorly understood, studies in animal models revealed loss of dopamine and the dopaminergic neurons harbouring the neurotransmitter to be the principal cause behind this neuro-motor disorder. |
2021-10-11 |
2023-08-13 |
mouse |
| Pavel A Markin, Alex Brito, Natalia E Moskaleva, Franco Tagliaro, Vadim V Tarasov, Michael R La Frano, Mark V Savitskii, Svetlana A Appolonov. Short- and medium-term exposures of diazepam induce metabolomic alterations associated with the serotonergic, dopaminergic, adrenergic and aspartic acid neurotransmitter systems in zebrafish (Danio rerio) embryos/larvae. Comparative biochemistry and physiology. Part D, Genomics & proteomics. vol 38. 2021-10-04. PMID:33610025. |
short- and medium-term exposures of diazepam induce metabolomic alterations associated with the serotonergic, dopaminergic, adrenergic and aspartic acid neurotransmitter systems in zebrafish (danio rerio) embryos/larvae. |
2021-10-04 |
2023-08-13 |
zebrafish |
| Sara Dominguez, Eugene Varfolomeev, Robert Brendza, Kim Stark, Joy Tea, Jose Imperio, Hai Ngu, Timothy Earr, Oded Foreman, Joshua D Webster, Amy Easton, Domagoj Vucic, Baris Bingo. Genetic inactivation of RIP1 kinase does not ameliorate disease in a mouse model of ALS. Cell death and differentiation. vol 28. issue 3. 2021-10-01. PMID:32994544. |
on the other hand, genetic inactivation of rip1 kinase activity ameliorated the depletion of the neurotransmitter dopamine in a toxin model of dopaminergic neurodegeneration. |
2021-10-01 |
2023-08-13 |
mouse |
| Miranda L Fisher, James R Pauly, Brett Froeliger, Jill R Turne. Translational Research in Nicotine Addiction. Cold Spring Harbor perspectives in medicine. vol 11. issue 6. 2021-09-29. PMID:32513669. |
likewise, translational studies investigating single-nucleotide polymorphisms (snps) within the cholinergic, dopaminergic, and opioid systems have found high levels of involvement of these neurotransmitter systems in regulating the reinforcing aspects of nicotine in both humans and mouse models. |
2021-09-29 |
2023-08-13 |
mouse |
| Tomasz Maciej Stepniewski, Arturo Mancini, Richard Ågren, Mariona Torrens-Fontanals, Meriem Semache, Michel Bouvier, Kristoffer Sahlholm, Billy Breton, Jana Selen. Mechanistic insights into dopaminergic and serotonergic neurotransmission - concerted interactions with helices 5 and 6 drive the functional outcome. Chemical science. vol 12. issue 33. 2021-09-16. PMID:34522296. |
in this work, we combine molecular dynamics simulations, live-cell biosensor and electrophysiological assays to investigate the action of the neurotransmitter dopamine at the dopaminergic d |
2021-09-16 |
2023-08-13 |
Not clear |
| Débora Dreher Nabinger, Stefani Altenhofen, Júlia Vasconcellos Peixoto, Julia Maria Kuhl da Silva, Robert Gerlai, Carla Denise Bona. Feeding status alters exploratory and anxiety-like behaviors in zebrafish larvae exposed to quinpirole. Progress in neuro-psychopharmacology & biological psychiatry. vol 108. 2021-09-02. PMID:33212194. |
they showed that consumption of food, a naturally rewarding stimulus known to engage the dopaminergic system, made this neurotransmitter system more susceptible to quinpirole's effects. |
2021-09-02 |
2023-08-13 |
human |
| Auxiliadora Mena, Sandra López, Juan C Ruiz-Salas, Aarón Fernández, Francisco J Pérez-Díaz, Juan C Lópe. Sensitivity to amphetamine in prepulse inhibition response requires a mature medial prefrontal cortex. Behavioral neuroscience. vol 135. issue 1. 2021-09-02. PMID:33734732. |
nevertheless, this neurotransmitter could not be involved in the expression of ppi because the administration of a dopaminergic agonist was ineffective in pnd-28 period. |
2021-09-02 |
2023-08-13 |
rat |
| Shahram Zarrabian, Shole Jamali, Soheila Fazli-Tabaei, Abbas Haghparas. The cross-talk between dopaminergic and nitric oxide systems in the medial septal nucleus, and their distinct effects on anxiety-like behaviors in male rats. Journal of psychiatric research. vol 141. 2021-08-25. PMID:34198193. |
in this study, we investigated the possible interaction between the dopaminergic and nitric oxide (no) neurotransmitter systems in the medial septal nucleus and their roles in anxiety-like behaviors using elevated plus-maze (epm) test in male rats. |
2021-08-25 |
2023-08-13 |
rat |
| Alice Powell, Catriona Ireland, Simon J G Lewi. Visual Hallucinations and the Role of Medications in Parkinson's Disease: Triggers, Pathophysiology, and Management. The Journal of neuropsychiatry and clinical neurosciences. vol 32. issue 4. 2021-08-16. PMID:32374649. |
while dopaminergic medications have long been associated with pd psychosis, a clear causal link has not been established, and other neurotransmitter systems, particularly noradrenaline, serotonin, and acetylcholine, are implicated and important. |
2021-08-16 |
2023-08-13 |
Not clear |
| Lisa M Smits, Stefano Magni, Kaoru Kinugawa, Kamil Grzyb, Joachim Luginbühl, Sonia Sabate-Soler, Silvia Bolognin, Jay W Shin, Eiichiro Mori, Alexander Skupin, Jens C Schwambor. Single-cell transcriptomics reveals multiple neuronal cell types in human midbrain-specific organoids. Cell and tissue research. vol 382. issue 3. 2021-08-10. PMID:32737576. |
human midbrain organoids (hmos) have been described to contain midbrain-specific dopaminergic neurons that release the neurotransmitter dopamine. |
2021-08-10 |
2023-08-13 |
human |
| Renáta Androvičová, James G Pfaus, Saak V Ovsepia. Estrogen pendulum in schizophrenia and Alzheimer's disease: Review of therapeutic benefits and outstanding questions. Neuroscience letters. vol 759. 2021-08-06. PMID:34116197. |
we discuss specific effects of estrogen deficit on neurotransmitter systems such as cholinergic, dopaminergic, serotoninergic, and glutamatergic. |
2021-08-06 |
2023-08-13 |
Not clear |
| Yadan Zhao, Zichen Zhang, Siru Qin, Wen Fan, Wei Li, Jingyi Liu, Songtao Wang, Zhifang Xu, Meidan Zha. Acupuncture for Parkinson's Disease: Efficacy Evaluation and Mechanisms in the Dopaminergic Neural Circuit. Neural plasticity. vol 2021. 2021-07-29. PMID:34221005. |
it has also been found that acupuncture can protect dopaminergic neurons from degeneration via antioxidative stress, anti-inflammatory, and antiapoptotic pathways as well as modulating the neurotransmitter balance in the basal ganglia circuit. |
2021-07-29 |
2023-08-13 |
Not clear |
| Efthalia Angelopoulou, Yam N Paudel, Christina Piperi, Awanish Mishr. Neuroprotective potential of cinnamon and its metabolites in Parkinson's disease: Mechanistic insights, limitations, and novel therapeutic opportunities. Journal of biochemical and molecular toxicology. vol 35. issue 4. 2021-07-27. PMID:33491302. |
in vivo evidence has demonstrated that oral administration of cinnamon powder and sodium benzoate may protect against dopaminergic cell death, striatal neurotransmitter dysregulation, and motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse models of pd. |
2021-07-27 |
2023-08-13 |
mouse |